Bengaluru, Karnataka Aug 7, 2021 (Issuewire.com) - protocols.io and Curadigm Datalytics are partnering to promote the protocols.io platform for biopharmaceutical companies.
Since February 2021, protocols.io and Curadigm have been working together on the curation and import of research methods. The current announcement extends the collaboration, building on the experience of the Curadigm team with sales of research software for pharmaceutical and biotech companies.
Dr. Lenny Teytelman, CEO and co-founder of protocols.io said of the partnership, "We have been deeply impressed by the professionalism, attention to detail, and grasp of science and method-writing by the Curadigm team in terms of their curation services. And we are excited to work together with Curadigm to expand the adoption of protocols.io among biopharma companies, improving their internal reproducibility and research efficiency."
The CEO of Curadigm, Dr. Jesintha Maniraja, said, "As a curation partner, I am extremely impressed with the platform. protocols.io significantly helps researchers and organizations on multiple aspects by ensuring that the protocols are structured, organized and secured. It enables interoperability among research groups within the same organization, minimizes redundancies, as well increases reproducibility of the results through embedded version control mechanisms, and most importantly saves time and cost. We are very excited to take this perfect platform to pharma, biotech and other life science sectors".
About protocols.io
protocols.io was conceived in 2012 by geneticist Lenny Teytelman, and computer scientists Alexei Stoliartchouk and Irinia Makkaveeva to facilitate science communication and rapid sharing of knowledge. The protocols.io platform enables academic and industry researchers to record and share detailed up to date methods for research. The company is in Berkeley, California. More information is available at www.protocols.io.
About Curadigm
Curadigm Datalytics is a data curation company that started its operation in early 2020 with the mission to bring evidence-based precise information to enable research, discovery and innovation in life sciences. Curadigm's core edge revolves around biomedical content management workflow including biological data curation, data harmonization and building knowledgebases. It brings cutting-edge approaches, multi-dimensional processes and delivers high-quality results with excellent turnaround times. The vision is to become the most valuable and preferred data curation partner across industries. The company is in Bangalore, India. More information is available at www.curadigmdata.com
Media Contact
Curadigm Datalytics
Source :Curadigm Datalytics
This article was originally published by IssueWire. Read the original article here.
